eMedicine Specialties > Allergy and Immunology > Urticaria and Angioedema
Urticaria
Updated: Jun 5, 2009
Introduction
Background
Urticaria, or hives, is a common skin condition that affects 15-25% of the population at some point in their lives.1 Most cases of urticaria are self-limited and of short duration, but when urticaria becomes chronic, it can be a very problematic and frustrating condition, both for the patient and for the clinician.
Urticaria is classified as either acute or chronic. Acute urticaria is defined as urticaria that has been present for less than 6 weeks. Chronic urticaria is defined as urticaria that has been continuously or intermittently present for at least 6 weeks.1 The 6-week period is a guide and not an absolute demarcation.
When no underlying cause is found, chronic urticaria is referred to as chronic idiopathic urticaria (CIU).
Angioedema is a condition that involves swelling of the deep dermal and subcutaneous/submucosal tissues. Some patients can have both urticaria and angioedema, occurring simultaneously or separately. Approximately 50% of patients have both urticaria and angioedema, while 40% have urticaria alone, and 10% have angioedema alone.2 See eMedicine article Angioedema for more details.
Pathophysiology
Skin lesions and pruritus occur, caused by an allergic or nonallergic mechanism.
Histamine is thought to be the most important biochemical mediator in urticaria.3 It is known to cause the classic wheal-and-flare response that is observed with urticaria and with positive results on allergy skin tests. Studies have shown that histamine is present in fluid taken from urticarial wheals.
Mast cells are the major histamine-releasing cells of the skin.4 Some studies report increased numbers of mast cells in urticarial lesions.1 The mast cell possesses high-affinity receptors for immunoglobulin E (IgE).4 In allergic reactions, adjacent IgE molecules, which are bound to the surface of mast cells by the high-affinity IgE receptors, are cross-linked by allergens, leading to the release of histamine and other mediators.
Histamine and the other mediators can be released by other nonallergic mechanisms as well. For example, neuropeptides are known to cause mast cell degranulation by a nonallergic mechanism. Neuropeptides may well be involved in dermographism and in emotional exacerbation of urticaria. In addition to histamine, other mast cell mediators are also thought to play a role in urticaria.5
Basophils also possess the high-affinity IgE receptor and may be involved in urticaria.6 Some patients with CIU may have underlying structural or functional defects in mast cells or basophils.7,8,9,10 The clinical role of these varying mast cell or basophil phenotypes is not yet known. One group found increased expression of the cytoplasmic phosphatase SHIP-2 (Src homology domain 2–containing-5'-inositol phosphatase) as a possible explanation for decreased basophil responsiveness to stimulation with polyclonal anti-IgE,11 but the role (if any) of this increased phosphatase expression in the pathophysiology of CIU is not yet known, and decreased responsiveness of basophils might be a consequence of having urticaria rather than its cause.12
Other inflammatory cells (ie, vide infra) are recruited into the lesional area in urticaria, particularly in chronic urticaria. These cells can release cytokines and chemokines that can cause histamine release or otherwise contribute to the pathology.
Histopathology
A lymphocytic infiltrate is commonly found in the lesions of both acute and chronic types of urticaria. Some urticarial lesions have a mixed cellular infiltrate, ie, a mixture of lymphocytes, polymorphonuclear leukocytes (PMNs), and other inflammatory cells.13 This mixed type of infiltrate seems to be particularly characteristic of certain refractory forms of chronic urticaria, such as autoimmune-mediated urticaria (see Causes).
The mixed infiltrate is similar to the histopathology of the allergic late-phase response. Some patients with particularly severe or atypical urticaria are found to have vasculitis on skin biopsy.14 Indeed, a spectrum in histopathology seems to exist, ranging from lymphocytic to vasculitic, that correlates approximately with disease severity, from mild to severe.
Frequency
International
Urticaria (chronic, acute, or both) affects 15-25% of the population at some time in their lives.1 CIU affects up to 0.5-1.5% of the population at some time in their lives.15 The incidence of acute urticaria is higher in people with atopy.1 The incidence of chronic urticaria is not increased in people with atopy.
Mortality/Morbidity
- Mortality is rare, unless the condition is accompanied by severe anaphylaxis or severe upper respiratory tract angioedema.
- Morbidity depends on the severity and duration of the condition. Of patients who have CIU, up to 20% can have symptoms for longer than 10 years. Some studies show chronic urticaria to be quite debilitating. One study finds that urticaria patients can have as much psychological, social, and occupational distress as patients who are awaiting triple coronary artery bypass surgery.16
Sex
Chronic urticaria affects females more often than males (the female-to-male ratio is approximately 4:1).1
Age
Acute urticaria occurs most commonly in children and young adults. CIU is more common in adults; middle-aged women seem to be most affected.
Clinical
History
- Typical features
- Typical lesions are described as edematous pink or red wheals of variable size and shape, with surrounding erythema. The lesions are often described as welts or hives.
- The lesions are generally pruritic.17 A painful or burning sensation may be described (such lesions are often associated with angioedema).18 Pruritus of nonlesional skin may also occur.
- Dermographism is often observed in conjunction with urticaria. Itching, erythema, and a raised wheal occur in areas that are scratched or stroked.19 Patients also may report pressure-induced hives, which can occur with elastic or tight clothing.20
- Individual lesions usually fade within 24 hours or so, but new lesions may be developing continuously. With delayed pressure urticaria, lesions may last as long as 48 hours. The lesions of urticarial vasculitis, which are palpable and purpuric, may last for several days or more and may lead to residual hyperpigmented changes.14
- Questions asked to determine possible allergic and nonallergic causes
- Are the hives associated with any foods? Have any new foods been added to the diet?
- Is the patient taking any regular medications or have any new medicines been started? In particular, ask about aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), antibiotics, over-the-counter medications, herbs, and supplements.
- Does the patient have any recent or chronic infections?
- Are the hives caused by any physical stimuli (e.g. heat, cold, pressure, vibration)?
- Does the patient have any chronic medical conditions?
- Is the urticaria associated with any substances that are inhaled or in contact with the skin (which may occur in an occupational setting)?
- Is the urticaria associated with insect bites or stings?
Physical
- If any features of anaphylaxis (eg, hypotension, respiratory distress, stridor, gastrointestinal distress) are present, immediate medical intervention should occur.
- Look for typical skin lesions, which are edematous pink or red wheals of variable size and shape, with surrounding erythema. Also, look for any atypical skin lesions. Lesions that are purpuric, nonblanchable, and palpable are characteristic of urticarial vasculitis. These lesions may leave residual pigmented changes. Tiny pinpoint hives are characteristic of cholinergic urticaria.21
- Examine for dermographism. The skin can be scratched with the end of a tongue blade or similar blunt object and observed over the next 5-15 minutes for the development of whealing with erythema.
- Look for any features of angioedema (deep tissue or submucosal edema).22
- The remainder of the physical examination should be used to investigate any suspicions that were raised by the history.
Causes
- Food allergies
- Food allergy should be considered in acute urticaria and urticaria in children.
- Food allergy is unlikely to be a cause in adults with chronic urticaria, especially if it is not obvious by the history. It occurs in fewer than 2% of cases.
- Food additives or preservatives have been reported to be a cause of chronic urticaria in 3-4% of cases.12,23,24 Data are scarce and questionable.
- Drug allergies
- Allergic reactions to a wide variety of drugs can occur. Theoretically, almost any drug can cause an allergic reaction.
- Antibiotics, such as penicillin, have been implicated most frequently.25 Urticarial reactions to penicillin can occur as long as 14 days after a course of treatment has stopped. In this situation, serum sickness may be present.
- Allergic reactions to a wide variety of drugs can occur. Theoretically, almost any drug can cause an allergic reaction.
- Contact urticaria is an allergic reaction to a substance that comes into contact with the skin (eg, an occupational exposure).
- Papular urticaria is a variation of urticaria caused by insect bites; the lesions may last longer than 24 hours.
- Other immediate hypersensitivity allergic reaction to an ingested, inhaled, or percutaneously inoculated substance (eg, latex, stinging insects, occupational exposures)
- Nonallergic release of mediators
- A number of drugs, such as aspirin, NSAIDs, opiates, succinylcholine, and certain antibiotics (eg, polymyxin, ciprofloxacin, rifampin, vancomycin, some beta-lactams) can cause urticaria by a nonallergic mechanism rather than by IgE-mediated hypersensitivity.
- Certain foods or beverages, such as spoiled fish (scombroidosis), aged cheeses, or red wine: These foods can contain histidine, which is closely related to histamine. These foods often are listed as causes of urticaria in the literature, but experimental evidence is scarce.
- Certain venoms
- Radiocontrast media sensitivity is not related to iodine, fish, or shellfish allergy.
- Medical causes
- Infectious causes
- Urticaria has been reported with certain viral infections, such as acute viral syndromes, hepatitis (A, B, and C), Epstein-Barr virus, and herpes simplex virus. Urticaria has also been reported with chronic parasitic infections.
- Urticaria may possibly be caused by sinusitis, cutaneous fungal infections, Helicobacter pylori infection, or other occult infection. These causes have been reported in the literature, but data are not strongly supported.12,26,27,28,29
- Hormonal causes
- Endocrine tumors (rare)
- Ovarian pathology (rare)
- Oral contraceptive use or changes in the menstrual cycle: Patients commonly report worsening of hives with the menstrual cycle. This may be hormonally mediated, but be sure to consider cyclical use of analgesics as a possible etiology.
- Cryoglobulinemias (eg, associated with hepatitis C, chronic lymphocytic leukemia)
- Serum sickness
- Other immune complex–mediated inflammation
- Systemic lupus erythematosus, rheumatoid arthritis, juvenile rheumatoid arthritis, or other rheumatological diseases (these are rare causes of urticaria)
- Urticaria has been reported with both hypothyroidism and hyperthyroidism and in euthyroid patients with antithyroid antibodies30 (ie, vide infra).
- Lymphoreticular malignancies (eg, chronic lymphocytic leukemia)
- Infectious causes
- Physical causes (physical urticaria)
- Cold
- Pressure: In addition to being an isolated cause of urticaria, a delayed response to pressure (delayed pressure urticaria) occurs in up to 40% of patients with chronic idiopathic urticaria (CIU).
- Vibration
- Cholinergic (triggered by heat, exercise, or emotional stress)
- Sunlight
- Water
- Dermographism (can occur as an isolated condition; can occur concomitantly with CIU in about 50% of cases)
- Exercise
- Chronic idiopathic urticaria (CIU)
- Urticaria is classified as idiopathic when no specific cause is identified by history, physical examination, or laboratory findings.
- Eighty to 90% of cases of chronic urticaria can be classified as idiopathic.13
- These patients may have concomitant physical urticaria.
- Idiopathic CIU can be separated into 2 categories, autoimmune and unknown.
- Autoimmune component
- Studies have shown that as many as 40-60% of cases of CIU have an autoimmune component.13 These studies found that sera from many of these patients, when injected intradermally, cause a wheal-and-flare reaction.13,31 This is called an autologous serum skin test. Furthermore, these sera can cause a release of histamine from basophils in vitro.7,31,32
- Further studies have found that 25-60% of patients have autoantibodies directed against high-affinity IgE receptors.33,34 The role of these autoantibodies is still unclear. They may bind to the high-affinity IgE receptors on mast cells and basophils, triggering the release of mediators, in a process that is thought to be complement-dependent.
- Five to 10% of patients have autoantibodies directed against the IgE molecule.33,34 The role of these autoantibodies is still unclear. They may attach to IgE molecules that are bound to mast cells (or basophils), triggering the release of mediators.
- Unknown cause or association
- In the remaining 40-60% of cases of CIU, the cause is unidentified. Numerous other possible causes have been suggested but have not been substantiated in the literature.
- As discussed previously, preliminary evidence has shown that some patients with CIU appear to have abnormal basophil signaling, with hyporesponsive basophils, but the pathophysiological role of this is still unknown.7,8,9,10,11,12
- A higher frequency of thyroid autoimmunity occurs in patients with chronic urticaria.30 These patients have autoantibodies directed against thyroid proteins but may be euthyroid. Some authors have found that treatment of these euthyroid patients with thyroxine leads to an improvement in urticaria,35 but other authors have not been able to reproduce this finding.36 Some have speculated that the thyroid autoantibodies cause inflammation in the thyroid, leading to release of cytokines, which, in turn, decreases the threshold for mast cell mediator release. Others have suggested that the thyroid autoantibodies are merely markers for autoimmunity. For example, patients with thyroid autoantibodies are more likely to have other autoantibodies, such as the anti-IgE receptor and anti-IgE discussed above, but this finding is not absolute.37
- Occult infections and food additives have been reported to be causes of CIU in a small number of patients, but the data are scarce and questionable, as discussed previously.
- Other histamine-releasing factors in the serum that cause a wheal-and-flare reaction independent of IgE or the high-affinity IgE receptor may be present. Experimental evidence for this is lacking.
More on Urticaria |
Overview: Urticaria |
| Differential Diagnoses & Workup: Urticaria |
| Treatment & Medication: Urticaria |
| Follow-up: Urticaria |
| Multimedia: Urticaria |
| References |
| Next Page » |
References
Kaplan AP. Urticaria angioedema. In: Adkinson Jr NFY, Busse WW, Bochner BS, Holgate ST, Simons FER (Eds). Allergy: principles and practice. Philadelphia: Mosby; 2003:1537 – 1558.
Kaplan AP. Chronic urticaria and angioedema. N Engl J Med. 2002;346:175-179.
Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. Jun 3 1993;328(22):1599-604. [Medline].
Brodell LA, Beck LA, Saini SS. Pathophysiology of chronic urticaria. Ann Allergy Asthma Immunol. Apr 2008;100(4):291-7; quiz 297-9, 322. [Medline].
Jacques P, Lavoie A, Bedard PM, Brunet C, Hebert J. Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission. J Allergy Clin Immunol. Jun 1992;89(6):1139-43. [Medline].
Sheikh J. Autoantibodies to the high-affinity IgE receptor in chronic urticaria: how important are they?. Curr Opin Allergy Clin Immunol. Oct 2005;5(5):403-7. [Medline].
Sabroe RA, Francis DM, Barr RM, Black AK, Greaves MW. Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol. Oct 1998;102(4 Pt 1):651-8. [Medline].
Vonakis BM, Saini SS. New concepts in chronic urticaria. Curr Opin Immunol. Dec 2008;20(6):709-16. [Medline].
Luquin E, Kaplan AP, Ferrer M. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy. Apr 2005;35(4):456-60. [Medline].
Brodell LA, Beck LA, Saini SS. Pathophysiology of chronic urticaria. Ann Allergy Asthma Immunol. Apr 2008;100(4):291-7; quiz 297-9, 322. [Medline].
Vonakis BM, Vasagar K, Gibbons SP Jr, Gober L, Sterba PM, Chang H. Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria. J Allergy Clin Immunol. Feb 2007;119(2):441-8. [Medline].
Kaplan AP. What the first 10,000 patients with chronic urticaria have taught me: A personal journey. J Allergy Clin Immunol. Dec 9 2008;[Medline].
Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol. Sep 2004;114(3):465-74; quiz 475. [Medline].
Davis MD, Brewer JD. Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome. Immunol Allergy Clin North Am. May 2004;24(2):183-213, vi. [Medline].
Gaig P, Olona M, Munoz Lejarazu D, Caballero MT, Dominguez FJ, Echechipia S. Epidemiology of urticaria in Spain. J Investig Allergol Clin Immunol. 2004;14(3):214-20. [Medline].
O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol. Feb 1997;136(2):197-201. [Medline].
Kaplan AP. Urticaria and angioedema. In: Middleton E, et al, (Eds). Allergy: Principles and Practices. St. Louis, Mo: Mosby-Year Book; 1998:1104-1118.
Charlesworth EN. Urticaria and angioedema: a clinical spectrum. Ann Allergy Asthma Immunol Jun. 1996;76(6):484-495.
Wong RC, Fairley JA, Ellis CN. Dermographism: a review. J Am Acad Dermatol. Oct 1984;11(4 Pt 1):643-52. [Medline].
Sheila MA, Stephen CD. Urticaria. Prim Care Clin Office Pract. 2008;35:141-157.
Hirschmann JV, Lawlor F, English JS, Louback JB, Winkelmann RK, Greaves MW. Cholinergic urticaria. A clinical and histologic study. Arch Dermatol. Apr 1987;123(4):462-7. [Medline].
Greaves M. Chronic urticaria. J Allergy Clin Immunol. Apr 2000;105(4):664-72. [Medline].
Goodman DL, McDonnell JT, Nelson HS, et al. Chronic urticaria exacerbated by the anti-oxidant food preservatives. J Allergy Clin Immunol. 1990;86:570-575.
Di Lorenzo G, Pacor ML, Mansueto P, Martinelli N, Esposito-Pellitteri M, Lo Bianco C. Food-additive-induced urticaria: a survey of 838 patients with recurrent chronic idiopathic urticaria. Int Arch Allergy Immunol. Nov 2005;138(3):235-42. [Medline].
Sheikh J. Advances in the treatment of chronic urticaria. Immunol Allergy Clin North Am. May 2004;24(2):317-34, vii-viii. [Medline].
Valsecchi R, Pigatto P. Chronic urticaria and Helicobacter pylori. Acta Derm Venereol. Nov 1998;78(6):440-2. [Medline].
Ozkaya-Bayazit E, Demir K, Ozguroglu E, Kaymakoglu S, Ozarmagan G. Helicobacter pylori eradication in patients with chronic urticaria. Arch Dermatol. Sep 1998;134(9):1165-6. [Medline].
Di Campli C, Gasbarrini A, Nucera E, Franceschi F, Ojetti V, Sanz Torre E. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci. Jun 1998;43(6):1226-9. [Medline].
Schnyder B, Helbling A, Pichler WJ. Chronic idiopathic urticaria: natural course and association with Helicobacter pylori infection. Int Arch Allergy Immunol. May 1999;119(1):60-3. [Medline].
Leznoff A, Josse RG, Denburg J, Dolovich J. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol. Aug 1983;119(8):636-40. [Medline].
Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza Black A, Greaves MW. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol. Mar 1999;140(3):446-52. [Medline].
Grattan CE, Francis DM, Hide M, Greaves MW. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy. Nov 1991;21(6):695-704. [Medline].
Ferrer M, Kinet JP, Kaplan AP. Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol. May 1998;101(5):672-6. [Medline].
Tong LJ, Balakrishnan G, Kochan JP, Kinet JP, Kaplan AP. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol. Apr 1997;99(4):461-5. [Medline].
Rumbyrt JS, Katz JL, Schocket AL. Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol. Dec 1995;96(6 Pt 1):901-5. [Medline].
Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol. Jul 1989;84(1):66-71. [Medline].
Irinyi B, Szeles G, Gyimesi E, Tumpek J, Heredi E, Dimitrios G. Clinical and laboratory examinations in the subgroups of chronic urticaria. Int Arch Allergy Immunol. 2007;144(3):217-25. [Medline].
Beltrani VS. Urticaria: reassessed. Allergy Asthma Proc. May-Jun 2004;25(3):143-9. [Medline].
Federman DG, Kirsner RS, Moriarty JP, Concato J. The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol. Nov 2003;49(5):861-4. [Medline].
Soundararajan S, Kikuchi Y, Joseph K, Kaplan AP. Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol. Apr 2005;115(4):815-21. [Medline].
Kikuchi Y, Kaplan AP. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol. Jun 2001;107(6):1056-62. [Medline].
Yasnowsky KM, Dreskin SC, Efaw B, Schoen D, Vedanthan PK, Alam R. Chronic urticaria sera increase basophil CD203c expression. J Allergy Clin Immunol. Jun 2006;117(6):1430-4. [Medline].
Sheikh J. Effect of omalizumab on patients with chronic urticaria: issues with the determination of autoimmune urticaria. Ann Allergy Asthma Immunol. Jan 2008;100(1):88; author reply 88-9. [Medline].
Wong JT, Nagy CS, Krinzman SJ, Maclean JA, Bloch KJ. Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema. J Allergy Clin Immunol. May 2000;105(5):997-1001. [Medline].
Grattan CE. Aspirin sensitivity and urticaria. Clin Exp Dermatol. Mar 2003;28(2):123-7. [Medline].
O'Donnell BF, Barr RM, Black AK, Francis DM, Kermani F, Niimi N. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol. Jan 1998;138(1):101-6. [Medline].
Grattan CE, Francis DM, Slater NG, Barlow RJ, Greaves MW. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet. May 2 1992;339(8801):1078-80. [Medline].
Grattan CE, O'Donnell BF, Francis DM, Niimi N, Barlow RJ, Seed PT. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol. Aug 2000;143(2):365-72. [Medline].
Vena GA, Cassano N, Colombo D, Peruzzi E, Pigatto P. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. J Am Acad Dermatol. Oct 2006;55(4):705-9. [Medline].
Werni R, Schwarz T, Gschnait F. Colchicine treatment of urticarial vasculitis. Dermatologica. 1986;172(1):36-40. [Medline].
Ruzicka T, Goerz G. Systemic lupus erythematosus and vasculitic urticaria. Effect of dapsone and complement levels. Dermatologica. 1981;162(3):203-5. [Medline].
Nettis E, Dambra P, D'Oronzio L, Loria MP, Ferrannini A, Tursi A. Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. Arch Dermatol. Jan 2001;137(1):99-100. [Medline].
Asero R, Tedeschi A, Lorini M. Leukotriene receptor antagonists in chronic urticaria. Allergy. May 2001;56(5):456-7. [Medline].
Gober LM, Sterba PM, Eckman JA, Saini SS. Effect of anti-IgE (omalizumab) in chronic idiopathic urticaria (CIU) patients. J Allergy Clin Immunol. 2008;121:AB#566.
Najib U, Sheikh J. An update on acute and chronic urticaria for the Primary Care Provider. Postgrad Med. Jan 2009;121(1): ISSN – 0032-5481, e-ISSN:1941-9260.
Breneman DL. Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Ann Pharmacother. Oct 1996;30(10):1075-9. [Medline].
Finn AF Jr, Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. Nov 1999;104(5):1071-8. [Medline].
Goldsobel AB, Rohr AS, Siegel SC, Spector SL, Katz RM, Rachelefsky GS. Efficacy of doxepin in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. Nov 1986;78(5 Pt 1):867-73. [Medline].
Bleehen SS, Thomas SE, Greaves MW, Newton J, Kennedy CT, Hindley F. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study. Br J Dermatol. Jul 1987;117(1):81-8. [Medline].
Toubi E, Blant A, Kessel A, Golan TD. Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy. Mar 1997;52(3):312-6. [Medline].
Further Reading
Keywords
urticaria, hives, acute urticaria, chronic urticaria, chronic idiopathic urticaria, CIU, angioedema, welts, pruritus, dermographism, erythema, itching, delayed pressure urticaria, urticarial vasculitis, anaphylaxis








Overview: Urticaria